Investigating the Role of Antioxidants in Drug Development
American Journal Of Pharmacy And Pharmacology · 28.02.2023 · 4 (1) · 1-5
DOI: 10.71465/ajpp.2291 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 28.02.2023. Verfasst von Dr. William Clarke.
Abstract (Originalsprache)
Antioxidants have gained significant attention in recent years for their potential therapeutic effects in various diseases, including cardiovascular disorders, cancer, neurodegenerative diseases, and diabetes. As free radicals and reactive oxygen species (ROS) play a critical role in cellular damage and disease progression, antioxidants serve as key modulators in preventing oxidative stress. This article explores the role of antioxidants in drug development, examining their mechanisms of action, potential therapeutic benefits, and challenges in integrating antioxidants into clinical treatments. We also discuss the current state of antioxidant-based drug formulations and the future directions for antioxidant therapies in various diseases.
Zitieren
APA
Clarke, D. W. (2023). Investigating the Role of Antioxidants in Drug Development. American Journal Of Pharmacy And Pharmacology, 4(1), 1-5. https://doi.org/10.71465/ajpp.2291
Vancouver
Clarke DW. Investigating the Role of Antioxidants in Drug Development. American Journal Of Pharmacy And Pharmacology. 2023;4(1):1-5. doi:10.71465/ajpp.2291
BibTeX
@article{Clarke2023,
author = {Clarke, Dr. William},
title = {Investigating the Role of Antioxidants in Drug Development},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2023},
volume = {4},
number = {1},
pages = {1--5},
doi = {10.71465/ajpp.2291}
}
EUVIMED